Back to Screener

Healthcare

Swedencare AB (publ)(SWDCF)

Live Price

Offline

$3.13

+0.00% today

1Y Change

-23.66%

Window

Jun 20, 2025 β†’ Jun 18, 2026

Market Cap
$4.30B
Revenue Growth
+6.1%
EPS Growth
-43.5%
Dividend Yield
1.0%

Coverage: 254 bars Β· Jun 20, 2025 β†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Swedencare AB (publ) (SWDCF) is a Healthcare stock with a market cap of $4.30B and listed on OTC. The stock last traded around $3.13 and down 23.7% across the available one-year price window (Jun 20, 2025 β†’ Jun 18, 2026). Baseline metrics include revenue growth of +6.1%, EPS growth of -43.5%, a dividend yield of 1.0%. What stands out right now is revenue +6.1%, EPS -43.5%, free cash flow -4.2% with operating margin 5.4% and ROIC 1.0%. The dividend is present but secondary, with a yield around 1.0%. Valuation already assumes a fairly strong business story at P/E 87.0 and price/sales 1.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SWDCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Near sector median

+6.1% vs +7.6% peer median

Operating Margin

Below sector median

+5.4% vs +19.4% peer median

P/E

Above sector median

87.0 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on Apr 23, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at +6.1% and EPS is at -43.5%, with operating margin around 5.4%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 1.0%, which matters if the thesis depends on income as much as growth.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged +9.1% over the next 5 trading days and finished higher after 2 of those reports.

View quarter-by-quarter reaction table
QuarterEPS Ξ”1D5D20D
2026
Apr 23, 2026
β€”+0.0%+0.0%+0.0%
2026
Feb 12, 2026
-63.8%+0.0%+7.2%+7.2%
2025
Oct 22, 2025
+4.9%+20.1%+20.1%+20.1%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SWDCF

β€”

Normalized return

SPY

β€”

S&P 500

Excess Return

β€”

Relative to SPY

SWDCF Max Drawdown

-48.35%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SWDCF and SPY.

Calendar-year return history is still loading or unavailable.
Swedencare AB (publ) logo

Company Overview

Swedencare AB (publ)

Other OTC

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. It offers ProDen PlaqueOff powder, a food supplement for cats and dogs, which reduce the formation of plaque and tartar; ProDen PlaqueOff dental bites, a pet dental product; ProDen PlaqueOff powder cat; ProDen PlaqueOff dental bones for dogs; ProDen PlaqueOff mini dental care bones, a chewy bone for smaller dogs; and ProDen PlaqueOff soft chews for dogs and cats. The company also provides dietary supplements for cats, dogs, and horses under the NutriScience brand, such as Glucosamine and Stomax used to renew joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid for joints and mobility; KalmAid, which helps to calm nervous dogs; and OmegaAid and RevitalAid, a feed supplement used for healthy skin and coat. In addition, it develops and manufactures equine supplements, including Gastrocare used to relieve gastric pain and improve appetite; Equine Gold, which helps horse to thrive; ArthriAid used to aid horse's own natural manufacture of cartilage; and AnxiKalm, a supplement to calm excitable horses. Further, the company provides ProDen PlaqueOff teeth and gums, a natural food supplement to enhance dental hygiene and prevent tartar buildup for human. It distributes its products through pharmacies, veterinary clinics, pet shops, animal hospital, and online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in MalmΓΆ, Sweden.

Leadership
Hakan Lagerberg
IPO Date
Jan 11, 2022
Employees
579
Street Address
Medeon Science Park
Mailing
MalmΓΆ, 205 12
Region
MalmΓΆ, SE
Reporting Currency
USD
Investor Line
46 04 08 59 33
Last Updated
May 5, 2026
ISIN: SE0015988167
Reports in USD

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
87.0
EV/EBITDA
12.7
Price/Sales
1.6
Price/Book
0.6

Growth

Revenue
+6.1%
EPS
-43.5%
Free Cash Flow
-4.2%

Profitability

Gross Margin
44.0%
Operating Margin
5.4%
Net Margin
1.8%
ROE
0.7%
ROIC
1.0%

Balance Sheet

Debt/Equity
0.25
Current Ratio
2.71

Earnings Reports

πŸ“… Last reportedApr 23, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”
β€”
Apr 23, 26
β€”
Est 0.03
β€”
β€”
Est 69374.0B
β€”
β€”
Feb 12, 26
βœ—
0.01
Est 0.03
-63.8%
73808.6B
Est 75380.2B
-2.1%
β€”
Oct 22, 25
βœ“
0.03
Est 0.03
+4.9%
75506.7B
Est 74024.1B
+2.0%
β€”
Jul 23, 25
βœ—
-0.00
Est 0.04
-111.9%
67793.1B
Est 725000.0B
-90.7%
β€”
Apr 24, 25
βœ—
0.02
Est 0.02
-33.1%
64479.8B
Est 65531.5B
-1.6%
β€”
Feb 13, 25
βœ—
0.01
Est 0.03
-49.8%
59850.0B
Est 62349.0B
-4.0%
β€”
Oct 23, 24
βœ—
0.01
Est 0.03
-41.9%
62031.9B
Est 64255.3B
-3.5%
β€”
Jul 25, 24
βœ—
0.01
Est 0.03
-60.5%
59652.0B
Est 62682.9B
-4.8%
β€”
Apr 25, 24
βœ—
0.02
Est 0.02
-11.7%
55218.6B
Est 57781.9B
-4.4%
β€”
Feb 15, 24
βœ—
-0.01
Est 0.02
-138.9%
62038.1B
Est 59165.7B
+4.8%
β€”
Sep 30, 23
βœ“
0.02
Est 0.01
+127.0%
55528.5B
Est 50903.3B
+9.1%
β€”
Jun 30, 23
βœ—
0.01
Est 0.02
-40.4%
52893.2B
Est 50977.3B
+3.8%
β€”
Mar 31, 23
βœ“
0.01
Est 0.01
+10.7%
50308.0B
Est 49585.1B
+1.5%
β€”
Feb 16, 23
βœ—
0.10
Est 0.34
-70.6%
48271.2B
Est 50820.3B
-5.0%
β€”
Oct 27, 22
βœ—
0.15
Est 0.18
-16.7%
43161.9B
Est 44908.3B
-3.9%
β€”
Jul 28, 22
βœ“
0.49
Est 0.10
+390.0%
45815.9B
Est 44219.6B
+3.6%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.